expansion offset anticipated challenges in SHL sales during the second quarter
of 2009. We also made significant progress this quarter optimizing our
distribution business, so that we solidify our presence in Tier I and II
hospital channels and remain on-track for net income contributions for the
full year. We continue to drive revenue growth and consistently generate cash
despite the uncertain regulatory environment in China's healthcare sector, and
we are confident in our ability to be a top-five pharmaceutical company in
The Company will hold a conference call at 8:00 am ET on August 7, 2009 to
discuss second quarter 2009 results. Listeners may access the call by dialing
1-866-761-0749 or 1-617-614-2707 for international callers, access code:
54060064. A webcast will also be available through AOB's website at
http://www.bioaobo.com . A replay of the call will be available through August
14, 2009. Listeners may access the replay by dialing 1-888-286-8010 or
1-617-801-6888 for international callers, access code: 18519426.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. is a pharmaceutical company
dedicated to improving health through the development, manufacture and
commercialization of a broad range of prescription and over the counter
products in China.
Statements made in this press release are forward-looking and are made
pursuant to the safe harbor provisions of the Securities Litigation Reform Act
of 1995. Such statements involve risks and uncertainties that may cause
actual results to differ materially from those set forth in these statements.
The economic, competitive, governmental, technological and other factors
identified in the Company's filings with the Securities and Exchange
Commission, including the Form 10-K for the year ended
Page: 1 2 3 4 5 6 7 8 Related biology technology :1
|SOURCE American Oriental Bioengineering, Inc.|
Copyright©2009 PR Newswire.
All rights reserved
. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA2
. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense3
. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.4
. American Oriental Bioengineering Announces Participation in September Investor Conferences5
. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting6
. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference7
. Tips from the Journals of the American Society for Microbiology8
. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting9
. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers10
. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot11
. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance